S&P 500   3,853.69 (+0.32%)
DOW   30,834.69 (-0.52%)
QQQ   329.76 (+1.33%)
AAPL   144.49 (+3.90%)
MSFT   229.61 (+1.62%)
FB   279.77 (+1.92%)
GOOGL   1,917.63 (+1.32%)
AMZN   3,348.10 (+1.70%)
TSLA   858.00 (+1.34%)
NVDA   551.10 (+0.47%)
BABA   264.10 (+2.12%)
CGC   33.45 (-1.04%)
GE   11.01 (-0.90%)
MU   82.83 (+0.67%)
AMD   95.06 (+2.45%)
NIO   64.20 (+3.63%)
T   28.57 (-1.24%)
F   11.43 (-0.78%)
ACB   10.66 (+0.09%)
BA   201.85 (-1.94%)
DIS   172.45 (-0.19%)
NFLX   569.06 (+0.69%)
GILD   66.48 (-0.69%)
S&P 500   3,853.69 (+0.32%)
DOW   30,834.69 (-0.52%)
QQQ   329.76 (+1.33%)
AAPL   144.49 (+3.90%)
MSFT   229.61 (+1.62%)
FB   279.77 (+1.92%)
GOOGL   1,917.63 (+1.32%)
AMZN   3,348.10 (+1.70%)
TSLA   858.00 (+1.34%)
NVDA   551.10 (+0.47%)
BABA   264.10 (+2.12%)
CGC   33.45 (-1.04%)
GE   11.01 (-0.90%)
MU   82.83 (+0.67%)
AMD   95.06 (+2.45%)
NIO   64.20 (+3.63%)
T   28.57 (-1.24%)
F   11.43 (-0.78%)
ACB   10.66 (+0.09%)
BA   201.85 (-1.94%)
DIS   172.45 (-0.19%)
NFLX   569.06 (+0.69%)
GILD   66.48 (-0.69%)
S&P 500   3,853.69 (+0.32%)
DOW   30,834.69 (-0.52%)
QQQ   329.76 (+1.33%)
AAPL   144.49 (+3.90%)
MSFT   229.61 (+1.62%)
FB   279.77 (+1.92%)
GOOGL   1,917.63 (+1.32%)
AMZN   3,348.10 (+1.70%)
TSLA   858.00 (+1.34%)
NVDA   551.10 (+0.47%)
BABA   264.10 (+2.12%)
CGC   33.45 (-1.04%)
GE   11.01 (-0.90%)
MU   82.83 (+0.67%)
AMD   95.06 (+2.45%)
NIO   64.20 (+3.63%)
T   28.57 (-1.24%)
F   11.43 (-0.78%)
ACB   10.66 (+0.09%)
BA   201.85 (-1.94%)
DIS   172.45 (-0.19%)
NFLX   569.06 (+0.69%)
GILD   66.48 (-0.69%)
S&P 500   3,853.69 (+0.32%)
DOW   30,834.69 (-0.52%)
QQQ   329.76 (+1.33%)
AAPL   144.49 (+3.90%)
MSFT   229.61 (+1.62%)
FB   279.77 (+1.92%)
GOOGL   1,917.63 (+1.32%)
AMZN   3,348.10 (+1.70%)
TSLA   858.00 (+1.34%)
NVDA   551.10 (+0.47%)
BABA   264.10 (+2.12%)
CGC   33.45 (-1.04%)
GE   11.01 (-0.90%)
MU   82.83 (+0.67%)
AMD   95.06 (+2.45%)
NIO   64.20 (+3.63%)
T   28.57 (-1.24%)
F   11.43 (-0.78%)
ACB   10.66 (+0.09%)
BA   201.85 (-1.94%)
DIS   172.45 (-0.19%)
NFLX   569.06 (+0.69%)
GILD   66.48 (-0.69%)
Log in
NYSE:MET

MetLife Stock Forecast, Price & News

$49.92
-0.94 (-1.85 %)
(As of 01/25/2021 09:39 AM ET)
Add
Compare
Today's Range
$49.86
Now: $49.92
$50.21
50-Day Range
$45.21
MA: $47.96
$52.12
52-Week Range
$22.85
Now: $49.92
$53.28
Volume16,226 shs
Average Volume5.30 million shs
Market Capitalization$44.93 billion
P/E Ratio8.20
Dividend Yield3.62%
Beta1.35
MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, tort settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, the company offers automobile, homeowners', and personal excess liability insurance products. Further, it provides fixed annuities and pension products; medical and credit insurance products; variable, universal, term, endowment, and whole life insurance products; variable, and fixed and indexed-linked annuities; and protection against long-term health care services. The company serves individuals, corporations and their employees, and other institutions and their members through independent agents, property and casualty specialists, sales forces, sales teams and relationship managers, and sponsoring organizations and affinity groups, as well as through career and independent agencies, bancassurance, direct marketing and e-commerce, brokers, and other third-party distribution channels. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
MetLife logo

MarketRank

Overall MarketRank

2.54 out of 5 stars

Finance Sector

27th out of 1,933 stocks

Life Insurance Industry

3rd out of 40 stocks

Analyst Opinion: 2.4Community Rank: 3.0Dividend Strength: 2.5Insider Behavior: 1.7Valuation: 3.1 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Life insurance
Sub-IndustryLife & Health Insurance
SectorFinance
CUSIP59156R10
Phone212-578-9500
Employees49,000
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$69.62 billion
Cash Flow$5.82 per share
Book Value$72.18 per share

Profitability

Net Income$5.90 billion

Miscellaneous

Market Cap$44.93 billion
Next Earnings Date2/3/2021 (Confirmed)
OptionableOptionable
$49.92
-0.94 (-1.85 %)
(As of 01/25/2021 09:39 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MET News and Ratings via Email

Sign-up to receive the latest news and ratings for MET and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











MetLife (NYSE:MET) Frequently Asked Questions

How has MetLife's stock price been impacted by Coronavirus (COVID-19)?

MetLife's stock was trading at $33.30 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, MET shares have increased by 49.9% and is now trading at $49.92.
View which stocks have been most impacted by COVID-19
.

Is MetLife a buy right now?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MetLife in the last twelve months. There are currently 2 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" MetLife stock.
View analyst ratings for MetLife
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than MetLife?

Wall Street analysts have given MetLife a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but MetLife wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Michel Khalaf's approval rating as MetLife's CEO?

308 employees have rated MetLife CEO Michel Khalaf on Glassdoor.com. Michel Khalaf has an approval rating of 89% among MetLife's employees.

When is MetLife's next earnings date?

MetLife is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021.
View our earnings forecast for MetLife
.

How can I listen to MetLife's earnings call?

MetLife will be holding an earnings conference call on Wednesday, February 3rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were MetLife's earnings last quarter?

MetLife, Inc. (NYSE:MET) issued its quarterly earnings data on Wednesday, November, 4th. The financial services provider reported $1.73 EPS for the quarter, topping the consensus estimate of $1.65 by $0.08. The financial services provider had revenue of $16.51 billion for the quarter, compared to the consensus estimate of $16 billion. MetLife had a trailing twelve-month return on equity of 8.17% and a net margin of 8.82%. MetLife's quarterly revenue was down 2.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.27 earnings per share.
View MetLife's earnings history
.

How often does MetLife pay dividends? What is the dividend yield for MetLife?

MetLife announced a quarterly dividend on Thursday, January 7th. Stockholders of record on Friday, February 5th will be given a dividend of $0.46 per share on Monday, March 15th. This represents a $1.84 dividend on an annualized basis and a dividend yield of 3.69%. The ex-dividend date is Thursday, February 4th.
View MetLife's dividend history
.

Is MetLife a good dividend stock?

MetLife pays an annual dividend of $1.84 per share and currently has a dividend yield of 3.62%. MetLife has been increasing its dividend for 3 consecutive year(s), indicating that it does not yet have a strock track record of dividend growth. The dividend payout ratio of MetLife is 30.11%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, MetLife will have a dividend payout ratio of 28.98% next year. This indicates that MetLife will be able to sustain or increase its dividend.
View MetLife's dividend history.

How will MetLife's stock buyback program work?

MetLife declared that its Board of Directors has authorized a share buyback plan on Friday, December 11th 2020, which allows the company to repurchase $3,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to buy up to 7.3% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company's management believes its shares are undervalued.

What price target have analysts set for MET?

12 analysts have issued 1-year price objectives for MetLife's shares. Their forecasts range from $32.00 to $57.00. On average, they expect MetLife's share price to reach $49.60 in the next twelve months. This suggests that the stock has a possible downside of 0.6%.
View analysts' price targets for MetLife
or view Wall Street analyst' top-rated stocks.

Are investors shorting MetLife?

MetLife saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 14,740,000 shares, an increase of 18.0% from the December 15th total of 12,490,000 shares. Based on an average trading volume of 5,700,000 shares, the days-to-cover ratio is presently 2.6 days. Approximately 1.9% of the company's shares are short sold.
View MetLife's Short Interest
.

Who are some of MetLife's key competitors?

What other stocks do shareholders of MetLife own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MetLife investors own include AT&T (T), Pfizer (PFE), Verizon Communications (VZ), General Electric (GE), International Business Machines (IBM), Exxon Mobil (XOM), Intel (INTC), Johnson & Johnson (JNJ), Cisco Systems (CSCO) and JPMorgan Chase & Co. (JPM).

Who are MetLife's key executives?

MetLife's management team includes the following people:
  • Mr. Michel Abbas Khalaf, CEO, Pres & Director (Age 57, Pay $5.79M)
  • Mr. John Dennis McCallion CPA, Exec. VP & CFO (Age 47, Pay $3.46M)
  • Mr. Bill Pappas, Exec. VP and Head of Global Technology & Operations (Age 51, Pay $2.3M)
  • Mr. Steven Jeffrey Goulart, Exec. VP & Chief Investment Officer (Age 62, Pay $3.22M)
  • Mr. Ramy Tadros, Exec. VP & Pres of U.S. Bus. (Age 45, Pay $2.6M)
  • Ms. Tamara Lynn Schock C.A., CPA, Exec. VP & Chief Accounting Officer (Age 49)
  • Mr. Pawan Verma, Exec. VP & Chief Information Officer (Age 44)
  • Mr. John Arthur Hall, Sr. VP & Head of Investor Relations
  • Mr. Stephen W. Gauster, Exec. VP & Gen. Counsel (Age 51)
  • Mr. Randolph J. Clerihue, Chief Communications Officer

What is MetLife's stock symbol?

MetLife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

Who are MetLife's major shareholders?

MetLife's stock is owned by a variety of institutional and retail investors. Top institutional investors include Wedge Capital Management L L P NC (0.06%), Candriam Luxembourg S.C.A. (0.03%), BTR Capital Management Inc. (0.02%), Exchange Traded Concepts LLC (0.02%), Farmers & Merchants Investments Inc. (0.02%) and State of Alaska Department of Revenue (0.01%). Company insiders that own MetLife stock include Catherine R Kinney, John D Mccallion and Steven J Goulart.
View institutional ownership trends for MetLife
.

Which major investors are selling MetLife stock?

MET stock was sold by a variety of institutional investors in the last quarter, including Douglas Lane & Associates LLC, Exchange Traded Concepts LLC, Gofen & Glossberg LLC IL, Cohen Klingenstein LLC, HGK Asset Management Inc., 6 Meridian, State of Alaska Department of Revenue, and Cullinan Associates Inc.. Company insiders that have sold MetLife company stock in the last year include Catherine R Kinney, and Steven J Goulart.
View insider buying and selling activity for MetLife
or view top insider-selling stocks.

Which major investors are buying MetLife stock?

MET stock was bought by a variety of institutional investors in the last quarter, including Candriam Luxembourg S.C.A., Farmers & Merchants Investments Inc., Kestra Advisory Services LLC, Park Avenue Securities LLC, IFM Investors Pty Ltd, Sowell Financial Services LLC, Hikari Power Ltd, and Pendal Group Limited.
View insider buying and selling activity for MetLife
or or view top insider-buying stocks.

How do I buy shares of MetLife?

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is MetLife's stock price today?

One share of MET stock can currently be purchased for approximately $49.92.

How big of a company is MetLife?

MetLife has a market capitalization of $44.93 billion and generates $69.62 billion in revenue each year. The financial services provider earns $5.90 billion in net income (profit) each year or $6.11 on an earnings per share basis. MetLife employs 49,000 workers across the globe.

What is MetLife's official website?

The official website for MetLife is www.metlife.com.

How can I contact MetLife?

MetLife's mailing address is 200 PARK AVENUE, NEW YORK NY, 10166. The financial services provider can be reached via phone at 212-578-9500.

This page was last updated on 1/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.